Syringe Free Vaccination with CAF01 Adjuvated Ag85B-ESAT-6 in Bioneedles Provides Strong and Prolonged Protection Against Tuberculosis

Open Access

Peer-reviewed

Research Article

Dennis Christensen ,

* E-mail: den@ssi.dk

Affiliation Statens Serum Institut, Department of Infectious Disease Immunology, Vaccine Delivery and Formulation Research, Copenhagen, Denmark
⨯
Thomas Lindenstrøm,

Affiliation Statens Serum Institut, Department of Infectious Disease Immunology, Vaccine Delivery and Formulation Research, Copenhagen, Denmark
⨯
Gijsbert van de Wijdeven,

Affiliation Bioneedle Technologies Group BV, Eindhoven, The Netherlands
⨯
Peter Andersen,

Affiliation Statens Serum Institut, Department of Infectious Disease Immunology, Vaccine Delivery and Formulation Research, Copenhagen, Denmark
⨯
Else Marie Agger

Affiliation Statens Serum Institut, Department of Infectious Disease Immunology, Vaccine Delivery and Formulation Research, Copenhagen, Denmark
⨯

Reader Comments (0)

Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.
Vaccination and immunization
Is the Subject Area "Vaccination and immunization" applicable to this article?

Thanks for your feedback.
HIV vaccines
Is the Subject Area "HIV vaccines" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Tuberculosis
Is the Subject Area "Tuberculosis" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
Vaccine development
Is the Subject Area "Vaccine development" applicable to this article?

Thanks for your feedback.